novo nordisk glp-1 Novo, Lilly buoyed by fast-growing drug sales Novo Nordisk CEO explains why
Description
Schedule a free GLP-1 consultation and save 20% off your first treatment.
Based on: Lebrun LJ, Lenaerts K, Kiers D, Pais de Barros JP, Le Guern N, Plesnik J, et al
:max_bytes(150000):strip_icc()/GettyImages-2228099453-84636f420a9142038b9a1e73c5280ef5.jpg)
Glucagon-like peptide-1 (GLP-1) is a natural hormone released in the intestines to regulate blood sugar levels and metabolism
GLP-1 receptor agonists represent a breakthrough for managing type-2 diabetes and obesity, offering metabolic benefits across multiple organ systems
Purpose We report a case in which the use of semaglutide for weight loss was associated with delayed gastric emptying and intraoperative pulmonary aspiration of gastric contents
